Opinion
Video
The Role of Weight Management and Glycemic Control in the Management of Type 2 Diabetes
Author(s):
Panelists discuss how treating obesity as the root cause can create a "virtuous cycle" where weight loss improves insulin resistance, reduces medication needs, and enables better physical activity, breaking the traditional reactive approach to diabetes management.
Clinical Barriers and Implementation Challenges
Healthcare providers face significant barriers in implementing comprehensive obesity management for patients with type 2 diabetes. The primary challenge is insufficient time for patient-centered, shared decision-making and motivational interviewing required to understand social determinants of health. Most providers lack access to multidisciplinary teams proven effective for chronic disease management, which operates as a team sport rather than individual physician responsibility.
Many providers lack adequate education and training in obesity management, as this wasn't part of traditional medical school curricula. This knowledge gap can create clinical inertia, leading to underutilization of beneficial programs and medications, particularly those offering cardio-renal risk reduction. The implementation of new evidence typically takes 5-7 years in healthcare systems, creating delays in adopting proven interventions.
Cost considerations present additional challenges, as medications and programs are expensive while affecting 40% of the population. Healthcare systems struggle to provide cost-effective access to beneficial treatments within limited resource constraints. Despite these barriers, the availability of evidence-based treatment strategies that impact cardio-renal risk and decrease mortality represents an unprecedented opportunity, requiring systematic approaches to overcome implementation obstacles.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
